Recent Company News

• 01:02 AM ET Nov 10, 2026
  

  FDA grants 510(k) clearance to bioMerieux's VITEK PRO (€91.30, 0.00)

• 02:52 AM ET Nov 03, 2026
  

  StreetAccount Summary - European pre-market trading update

• 01:01 AM ET Nov 09, 2026
  

  bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE FILMARRAY Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus (€93.30, 0.00)

• 10:36 AM ET Nov 03, 2026
  

  Transcript Intelligence: bioMerieux Q3 Sales and Revenue Guidance

• 10:36 AM ET Nov 03, 2026
  

  Transcript Intelligence: bioMerieux Q3 Sales and Revenue Themes

• 10:36 AM ET Nov 03, 2026
  

  Transcript Intelligence: bioMerieux Q3 Sales and Revenue Q&A

• 07:05 AM ET Nov 03, 2026
  

  Basic resources, tech, retail and autos the big decliners; healthcare, insurance and energy the main gainers:

• 04:09 AM ET Nov 03, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 01:12 AM ET Nov 03, 2026
  

  bioMerieux reports Q3 revenue €1.04B vs FactSet €1.02B [2 est, €1.01-1.02B] (€90.40, 0.00)